TSS
STIM icon

Two Sigma Securities’s Neuronetics STIM Stock Holding History

Two Sigma Securities’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,496
Closed -$24K – 1717
2020
Q1 		$24K Buy
+12,496
New +$39.1K ﹤0.01% 1223

Other funds holding STIM

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Securities's STIM Position: Q2 2020 in Review

Two Sigma Securities sold out of Neuronetics (STIM) in Q2 2020, closing a stake of 12,496 shares — an estimated $24K sold.

Two Sigma Securities first reported a position in STIM in Q1 2020 and held it in 1 quarter. The position peaked at $24K in Q1 2020. 55 funds tracked by Wall St. Rank hold STIM as of Q2 2020.

  • Two Sigma Securities reported no remaining Neuronetics position as of Q2 2020 after selling out during the quarter.
  • Two Sigma Securities sold 12,496 Neuronetics shares in Q2 2020, an estimated $24K.
  • Two Sigma Securities first reported a position in Neuronetics in Q1 2020 and held it in 1 quarter.
  • Two Sigma Securities's Neuronetics position peaked at $24K in Q1 2020.
  • 55 funds tracked by Wall St. Rank held Neuronetics as of Q2 2020.

Based on Two Sigma Securities's 13F filing for Q2 2020, filed 14 Aug 2020.